openPR Logo
Press release

Pneumococcal Vaccine Market Size, Share, Growth Insights and Report 2024-2032 | GSK plc, Pfizer Inc., Merck KGaA

10-15-2024 09:42 AM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Pneumococcal Vaccine Market

Pneumococcal Vaccine Market

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค:
โ€ข ๐“๐ก๐ž ๐ฉ๐ง๐ž๐ฎ๐ฆ๐จ๐œ๐จ๐œ๐œ๐š๐ฅ ๐ฏ๐š๐œ๐œ๐ข๐ง๐ž ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ฌ๐ข๐ณ๐ž ๐ฐ๐š๐ฌ ๐ฏ๐š๐ฅ๐ฎ๐ž๐ ๐š๐ญ ๐”๐’๐ƒ ๐Ÿ–.๐Ÿ๐Ÿ• ๐›๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ‘.
โ€ข ๐“๐ก๐ž ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ข๐ฌ ๐ž๐ฑ๐ฉ๐ž๐œ๐ญ๐ž๐ ๐ญ๐จ ๐ž๐ฑ๐ฉ๐š๐ง๐ ๐š๐ญ ๐š ๐‚๐€๐†๐‘ ๐จ๐Ÿ ๐Ÿ”.๐Ÿ’% ๐Ÿ๐ซ๐จ๐ฆ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’ ๐ญ๐จ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ.
โ€ข ๐“๐ก๐ž ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ข๐ฌ ๐ž๐ฑ๐ฉ๐ž๐œ๐ญ๐ž๐ ๐ญ๐จ ๐ ๐ซ๐จ๐ฐ ๐ญ๐จ ๐”๐’๐ƒ ๐Ÿ๐Ÿ’.๐Ÿ’๐Ÿ‘ ๐›๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ.

๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ:
Pneumococcal vaccines are created to safeguard children and adults from pneumonia-induced acute and severe infections. There are mainly two types of pneumococcal vaccines in existence: pneumococcal conjugate vaccine (PCV) and pneumococcal polysaccharide vaccine (PPSV). These vaccines are made up of various serotypes of pneumococcus that are combined to create a single dose for immunizing both children and adults. Various serotypes cause distinct pneumonia infections, with specific serotypes causing invasive pneumococcal disease, a more severe form of the illness.

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐…๐ซ๐ž๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐… ๐‚๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:
https://www.polarismarketresearch.com/industry-analysis/pneumococcal-vaccine-market/request-for-sample

๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐…๐š๐œ๐ญ๐จ๐ซ๐ฌ ๐š๐ง๐ ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ:
The increasing prevalence of pneumococcal disease in people of all ages is fueling the demand for pneumococcal vaccines in the upcoming years. Furthermore, government initiatives and health policies promoting widespread vaccination are the main drivers of the market. As governments place greater emphasis on vaccination to prevent diseases, the market for pneumococcal vaccines is projected to see significant expansion.

๐Š๐ž๐ฒ ๐๐š๐ซ๐ญ๐ข๐œ๐ข๐ฉ๐š๐ง๐ญ๐ฌ:
With so many businesses involved, the market is projected to become more competitive as it continues to grow.
Some of the major players participating in the pneumococcal vaccine market:
โ€ข GSK plc
โ€ข Pfizer Inc.
โ€ข Merck KGaA
โ€ข Serum Institute of India Pvt. Ltd.
โ€ข CSL Ltd.
โ€ข Sanofi S.A.
โ€ข Walvax Biotechnology Co., Ltd.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐Ÿ๐จ๐ซ ๐š ๐ƒ๐ข๐ฌ๐œ๐จ๐ฎ๐ง๐ญ ๐จ๐ง ๐ญ๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐๐ž๐Ÿ๐จ๐ซ๐ž ๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž:
https://www.polarismarketresearch.com/industry-analysis/pneumococcal-vaccine-market/request-for-discount-pricing

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง:
The pneumococcal vaccine market is primarily segmented based on the vaccine type, product type, end user, and region. Based on vaccine type analysis, in 2023, the pneumococcal polysaccharide vaccine segment held the largest market share. It covers a wide range of pneumococcal strains and has a proven track record in preventing severe infections in adults, especially those with pre-existing health issues.
Furthermore, according to the product type analysis, during the projection period, the Synflorix segment is anticipated to witness the highest CAGR due to its affordability; Synflorix is especially popular in countries with limited budgets, increasing its market share. The rapid growth rate of this pneumococcal vaccine is largely fueled by the increasing demand in developing regions, surpassing other similar vaccines.

๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž ๐“๐ก๐ž ๐‚๐จ๐ฆ๐ฉ๐ฅ๐ž๐ญ๐ž ๐‚๐จ๐ฆ๐ฉ๐ซ๐ž๐ก๐ž๐ง๐ฌ๐ข๐ฏ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐‡๐ž๐ซ๐ž:
https://www.polarismarketresearch.com/industry-analysis/pneumococcal-vaccine-market

๐๐ง๐ž๐ฎ๐ฆ๐จ๐œ๐จ๐œ๐œ๐š๐ฅ ๐•๐š๐œ๐œ๐ข๐ง๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐‡๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ
โ€ข The pneumococcal polysaccharide vaccine (PPV) segment accounted for the largest market share in 2023 primarily due to global acceptance and easy availability.
โ€ข The Pneumococcal conjugate vaccine (PCV) segment is expected to witness the highest growth over the study period, as PCV covers more range of the streptococcus pneumoniae.
โ€ข The Prevnar 13 segment accounted for the largest market share in 2023, as it caters to a wider range of age, and is more efficient in treating the disease.
โ€ข The Asia Pacific is projected to register the fastest growth over the study period, attributable to the increasing investment in pneumococcal vaccine development.
โ€ข The global players are GSK plc, Pfizer Inc, Merck, Serum Institute, CSL Ltd., and Sanofi.

๐Œ๐จ๐ซ๐ž ๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‹๐š๐ญ๐ž๐ฌ๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐›๐ฒ ๐๐จ๐ฅ๐š๐ซ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:
๐‚๐ฅ๐ข๐ง๐ข๐œ๐š๐ฅ ๐“๐ซ๐ข๐š๐ฅ ๐Ž๐ฎ๐ญ๐ฌ๐จ๐ฎ๐ซ๐œ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ
https://www.polarismarketresearch.com/industry-analysis/clinical-trials-outsourcing-market

๐Œ๐ž๐๐ข๐œ๐š๐ฅ ๐“๐š๐ฉ๐ž๐ฌ ๐š๐ง๐ ๐๐š๐ง๐๐š๐ ๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ
https://www.polarismarketresearch.com/industry-analysis/medical-tapes-and-bandages-market

๐Œ๐ข๐œ๐ซ๐จ๐›๐ข๐จ๐ฆ๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ซ๐ž๐ฉ๐š๐ซ๐š๐ญ๐ข๐จ๐ง ๐“๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ
https://www.polarismarketresearch.com/industry-analysis/microbiome-sample-preparation-technology-market

๐ˆ๐ฌ๐จ๐ญ๐ก๐ž๐ซ๐ฆ๐š๐ฅ ๐๐ฎ๐œ๐ฅ๐ž๐ข๐œ ๐€๐œ๐ข๐ ๐€๐ฆ๐ฉ๐ฅ๐ข๐Ÿ๐ข๐œ๐š๐ญ๐ข๐จ๐ง ๐“๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ
https://www.polarismarketresearch.com/industry-analysis/isothermal-nucleic-acid-amplification-technology-market

๐๐ซ๐จ๐ญ๐ž๐ข๐ง ๐„๐ฑ๐ฉ๐ซ๐ž๐ฌ๐ฌ๐ข๐จ๐ง ๐Œ๐š๐ซ๐ค๐ž๐ญ
https://www.polarismarketresearch.com/industry-analysis/protein-expression-market

Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pneumococcal Vaccine Market Size, Share, Growth Insights and Report 2024-2032 | GSK plc, Pfizer Inc., Merck KGaA here

News-ID: 3692804 • Views: โ€ฆ

More Releases from Polaris Market Research & Consulting

Software-Defined Anything (SDx) Market Set to Reach USD 383.65 Billion By 2034 with a Notable CAGR of 24.0%
Software-Defined Anything (SDx) Market Set to Reach USD 383.65 Billion By 2034 w โ€ฆ
Software-defined Anything (SDx) Market Insights, Size Revenue, Outlook, Overview, and Analysis. The software-defined anything (SDx) market was estimated to be worth USD 44.46 billion in 2024 and is predicted to expand to USD 383.65 billion by 2034, with a CAGR of 24.0% from 2025 to 2034. ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐’๐œ๐จ๐ฉ๐ž: This comprehensive study provides an accurate overview of the worldwide software-defined anything (SDx) market. Comprehensive analyses of sales volume, price, revenue, market share, andโ€ฆ
Cloud ITSM Market Achieves 26.18 Billion USD Valuation, with a Projected CAGR of 13.5% by 2032
Cloud ITSM Market Achieves 26.18 Billion USD Valuation, with a Projected CAGR of โ€ฆ
The size of the cloud information technology services management (ITSM) market was evaluated at USD 8.38 billion in 2023. The market is expected to grow from USD 9.50 billion in 2024 to USD 26.18 billion by 2032, exhibiting a CAGR of 13.5% between 2024-2032. ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐’๐œ๐จ๐ฉ๐ž The report focuses mostly on the growth promoters, market share, size, trends applications in various industries, and insight into recent developments and challenges in orderโ€ฆ
Green Ammonia Market Expected to Reach $32.57 Billion by 2032 with 69.6% CAGR
Green Ammonia Market Expected to Reach $32.57 Billion by 2032 with 69.6% CAGR
The green ammonia market size was valued at USD 281.16 million in 2023. It is projected to grow to USD 32,572.91 million by 2032, exhibiting a compound annual growth rate (CAGR) of 69.6% from 2024 to 2032. Market Definition: Green ammonia is produced by combining hydrogen from water with nitrogen from the air. It is a versatile fuel that has applications in gas turbines, generator sets, internal combustion engines, fuel cells,โ€ฆ
Personal Care Products Market Projected to Reach $252.79 Billion by 2032 with 5.4% CAGR
Personal Care Products Market Projected to Reach $252.79 Billion by 2032 with 5. โ€ฆ
Personal Care Products-Market Insights, Size Revenue, Outlook, Overview, and Analysis. The personal care products market was estimated to be worth USD 157.74 billion in 2023 and is predicted to expand to USD 252.79 billion by 2032, with a CAGR of 5.4% from 2024 to 2032. Report Scope: This comprehensive study provides an accurate overview of the worldwide personal care products market. Comprehensive analyses of sales volume, price, revenue, market share, andโ€ฆ

All 5 Releases


More Releases for Pneumococcal

Global To Invigorate The Intravenous Pneumococcal Vaccines Market
Pneumococcal vaccine is used to prevent infection caused by streptococcus pneumoniae bacteria. There are two types of pneumococcal vaccines: pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine. The Centers for Disease Control and Prevention (CDC) recommends pneumococcal conjugate vaccine for all children younger than two years of age, all adults 65 years or older, and for people 2-64 years old with certain medical conditions. The CDC recommends pneumococcal polysaccharide vaccine for allโ€ฆ
Pneumococcal Vaccines Market Demands and Gross Margin 2027
"Industry analysis is a crucial step in the current competitive market space that helps identify the right target customers and accordingly provide tailored solutions for their business needs. Every aspect and unique challenges put up by the particular industry are carefully taken into consideration while formulating these solutions. It also takes into consideration various government reforms, competitive environment, customer behavior, existing and upcoming business models, and ever-evolving technological developments. Industryโ€ฆ
Pneumococcal and Meningococcal Vaccines Market Analysis by Industry 2020
The Pneumococcal & Meningococcal Vaccines Market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and New innovations. The report contains a granular analysis of the present industry situations, market demands, revealโ€ฆ
Pneumococcal Vaccine Report on Global Pneumococcal Vaccine Market Development, p โ€ฆ
Latest Survey on Pneumococcal Vaccine Market: The Global Pneumococcal Vaccine market report value has been estimated considering the application and regional segments, market share, and size, while the forecast for each product type and application segment has been provided for the global markets. The Pneumococcal Vaccine report offers detailed profiles of the key players to bring out a clear view of the competitive landscape of the Pneumococcal Vaccine Outlook. It alsoโ€ฆ
Pneumococcal Vaccines Market | North America Dominated the Global Market
Transparency Market Research (TMR) has published a new report titled, โ€œPneumococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018โ€“2026โ€. According to the report, the global pneumococcal vaccines market was valued at US$ 7,247.6 Mn in 2017 and is anticipated expand at a CAGR of 3.3% from 2018 to 2026. Increase in patient pool, growth of the pharmaceutical industry, government initiatives to increase vaccination programs, riseโ€ฆ
Global Pneumococcal Vaccine Industry Market Analysis & Forecast 2018-2023
Global Pneumococcal Vaccine Industry Market results in aggravation noticeable all around sacs (known as alveoli) of the lungs, which brings about filling the alveoli with liquid (discharge cells), accordingly causing breathing issues. Pneumococcal Vaccine illness is regular in youthful youngsters, however more established grown-ups are at most serious danger of genuine pneumococcal diseases and even demise. Get sample copy of report: https://www.marketdensity.com/contact?ref=Sample&reportid=4396 Table of Contents 1 Industry Overview 1.1 Pneumococcal Vaccine Industry 1.1.1โ€ฆ